Clinical Trial Update: Phase III rhu_GM-CSF + 3 Induction Regimens in Adults With Acute Non-Lymphocytic Leukemia [Phase 3]

View source ↗

Summary

Phase III trial evaluating rhu_GM-CSF combined with three induction regimens in adults over 55 with acute non-lymphocytic leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• rhu_GM-CSF (granulocyte-macrophage colony-stimulating factor)

Snippet

Sponsor: Eastern Cooperative Oncology Group | Conditions: Adult Patients (Over 55) With Acute Non-Lymphocytic Leukemia | Phase 3 | Status: COMPLETED